AXIM Biotechnologies, Inc
AXIM Biotechnologies Inc. is a research and development company based in San Diego, CA, dedicated to advancing diagnostic solutions for ophthalmological conditions, particularly Dry Eye Disease (DED), through innovative rapid diagnostic tests. Founded in 2014, AXIM is notable for owning two of the five FDA-cleared diagnostic tests for DED, reflecting its commitment to improving patient outcomes.
In addition to its work in ophthalmology, AXIM is also developing a rapid 10-minute diagnostic test aimed at the early detection of cancer biomarkers. The company operates a vertically integrated platform that enables the development of diagnostic solutions tailored to diverse client needs.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.